PR Newswire Asia's news > Biotechnology

 < Previous page   |   Detail   |   Print    Next page > 
     
AAHRPP Accredits Five More Research Entities
2026-09-03T    Biotechnology   Health Care/Hospital   Higher Education   Medical/Pharmaceuticals 
Ivonescimab Meets Overall Survival Key Secondary Endpoint in Interim Analysis of Phase III HARMONi-2 Study, Demonstrating Statistically Significant and Clinically Meaningful Benefit Versus Pembrolizumab in First-Line PD-L1-Positive NSCLC
2026-09-03T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
EpiVax Launches AI-Enhanced Models for Immunogenicity Prediction
2026-09-02T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Alteogen Enters Option and License Agreement with Novartis for Development and Commercialization of Hybrozyme™-Enabled Subcutaneous Products
2026-09-02T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
NovaGo Therapeutics Closes USD 30 Million Series B Financing to Advance Proof-of-Concept Study in Acute Spinal Cord Injury
2026-09-02T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Norroy Bioscience Initiates Pivotal Phase III Clinical Trial of 177Lu-NYM032, a PSMA-Targeted Radioligand Therapy for mCRPC
2026-09-02T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to participate in trial for innovative mapping and pulsed field ablation system
2026-09-02T    Biotechnology   Health Care/Hospital   Medical Equipment 
Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway
2026-09-02T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Haier Biomedical Highlights Automated Biostorage and Connected Pharma Solutions at ISPE Singapore 2026
2026-09-01T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Haier Biomedical Highlights Automated Biostorage and Connected Pharma Solutions at ISPE Singapore 2026
2026-09-01T    Biotechnology   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.